Literature DB >> 4022136

Very rapid turnover of dopamine in noradrenaline cell body regions.

N E Andén, M Grabowska-Andén, S Lindgren, M Oweling.   

Abstract

The contents of dopamine, noradrenaline and their deaminated metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylethylene glycol (DOPEG) were determined in rats in two noradrenaline cell body regions, i.e., the superior cervical ganglion and the locus coeruleus, and in one dopamine cell body region, the substantia nigra. In the two noradrenaline cell body regions, the tyrosine hydroxylase inhibitor alpha-methyltyrosine rapidly lowered the contents of noradrenaline and DOPEG and it lowered the contents of dopamine and DOPAC even more rapidly. The dopamine-beta-hydroxylase inhibitor FLA-63 swiftly elevated the content of dopamine and it lowered the content of noradrenaline in the two noradrenaline regions, but it was ineffective in the substantia nigra. The monoamine oxidase inhibitor pargyline rapidly reduced the deaminated catechols and increased somewhat the contents of the two amines in the superior cervical ganglion and in the locus coeruleus. The alpha-methyltyrosine-induced disappearance of dopamine in the two noradrenaline cell body regions was markedly inhibited by FLA-63 and pargyline in combination, but not by only one of the two drugs. The results indicate that most of the dopamine in the superior cervical ganglion and in the locus coeruleus occurs in the cell body region of noradrenaline neurons, whereas only a minor part of the dopamine in the superior cervical ganglion is present in SIF cells. Axonal transport did not contribute to the disappearance of dopamine in the superior cervical ganglion. A high dose of reserpine reduced the contents of dopamine and noradrenaline in the superior cervical ganglion and in the locus coeruleus, indicating that most of the amines is present in storage granules.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022136     DOI: 10.1007/bf00501877

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Distribution of intravenously injected protein tracers in peripheral ganglia of adult mice.

Authors:  B Arvidson
Journal:  Exp Neurol       Date:  1979-02       Impact factor: 5.330

2.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

Authors:  A Björklund; O Lindvall
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

3.  Trans-synaptic modulation of dopamine metabolism in the rat superior cervical ganglion.

Authors:  F Karoum; C K Garrison; N Neff; R J Wyatt
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

4.  Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.

Authors:  L Peyrin; J M Cottet-Emard; F Javoy; Y Agid; A Herbet; J Glowinski
Journal:  Brain Res       Date:  1978-03-31       Impact factor: 3.252

5.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.

Authors:  T H Svensson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

6.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

7.  [Ultrastructural data on an eventual adrenergic modulation of the rat superior cervical ganglion].

Authors:  J Taxi; J Gautron; P L'Hermite
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-10

8.  Histochemical studies on a special catecholamine-containing cell type in sympathetic ganglia.

Authors:  K A Norberg; M Ritzén; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

9.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

10.  Dopamine beta-hydroxylase inhibitors. The preparation and the dopamine beta-hydroxylase inhibitory activity of some compounds related to dithiocarbamic acid and thiuramdisulfide.

Authors:  L Florvall; H Corrodi
Journal:  Acta Pharm Suec       Date:  1970-02
View more
  7 in total

1.  Activation of forebrain dopamine systems by phencyclidine and footshock stress: evidence for distinct mechanisms.

Authors:  M B Bowers; M J Bannon; F J Hoffman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Synthesis and utilization of catecholamines in the rat superior cervical ganglion following changes in the nerve impulse flow.

Authors:  N E Andén; M Grabowska-Andén
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.

Authors:  O Boulat; P Waldmeier; L Maitre
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Are the alpha 2-adrenoceptors in the noradrenaline cell body region of physiological significance?

Authors:  N E Andén; M Grabowska-Andén; T Nilsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

Review 5.  A new approach to biochemical evaluation of brain dopamine metabolism.

Authors:  I J Kopin; J H White; K Bankiewicz
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

6.  Stimulation of the synthesis of catecholamines in a sympathetic ganglion via cholinergic and non-cholinergic mechanisms.

Authors:  N E Andén; M Grabowska-Andén; L Klaesson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

7.  Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism.

Authors:  E Panula-Lehto; M Mäkinen; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.